Author Archives: Jake Crosby

Dr. Gary Kompothecras Helps Canary Party Hijack Hearings

drgaryjenmarkyacht

Addendum: Click above image to enlarge.

By Jake Crosby

Above is a photo of Canary Party Chairman Mark Blaxill and President Jennifer Larson with chiropractor Dr. Gary Kompothecras of 1-800-Ask-Gary fame on a yacht in Sarasota, Florida on April 30th, 2013 where they were meeting with congressmen, including Committee on Oversight & Government Reform (COGR) Chairman Darrell Issa. Jennifer Larson, in no ambiguous terms, made it clear whom she and Blaxill had to thank for meetings with congressmen in the above Facebook photo of her, Blaxill and Dr. Kompothecras:

“Thank you Dr. Gary Kompothecras. Dr. Gary made these meetings possible.”

Yes, thank you  Dr. Gary for making it possible for Mark Blaxill to hijack the congressional hearings. Dr. Kompothecras has considerable political influence and in recent years has given vast amounts of money to Congressman Issa’s campaign for Congress and those of other congressmen. Dr. Kompothecras’ political pull was key to having Issa commit to holding hearings on autism causation and the vaccine program in 2012.

Unfortunately, Dr. Kompothecras was also key in destroying what he helped launch. At the 2012 AutismOne conference, Kompothecras spilled the news of the upcoming congressional hearing to Mark Blaxill, who then undermined that hearing with the help of lobbyist Beth Clay, interfered with scientist Dr. Brian Hooker testifying on CDC’s research fraud and caused autism epidemic deniers Ari Ne’eman and Michael John Carley to show up instead, much to Kompothecras’ dismay. He was so angry about Ne’eman’s presence at the hearing that when Ne’eman offered to shake his hand, Kompothecras replied:

“I’m not gonna shake your hand you fucking clown!”

I cringed when Dr. Kompothecras bragged about this to me after the hearing. Yet his anger at Ari Ne’eman’s testifying did not stop him from giving Mark Blaxill a friendly pat on the shoulder at the hearing, despite Blaxill’s role in enabling Ne’eman to testify by having the hearing topic changed to the catch-all “federal response” on autism.

The disturbing details of how Blaxill hijacked the hearing did not deter Dr. Kompothecras from developing closer ties to Blaxill and Canary Party Dr. Hooker was pressured into “working with” Mark Blaxill by Dr. Kompothecras who made Hooker fear being cut off from COGR if he didn’t cooperate with Canary Party. That was when Canary Party put out an action alert that – unlike what Canary Party’s president promised to Dr. Brian Hooker – did not specifically ask Congress to investigate the CDC’s scientific misconduct.

Despite the false promise made to Dr. Hooker by Canary Party President Jennifer Larson that the Canary Party action alert would ask for an investigation specifically into CDC research fraud, Dr. Brian Hooker told me who the real architect of the action alert was:

“It was Mark’s doing. I called him on it after the action alert came out”

And in contrast to Mark Blaxill later claiming that it was Issa who wanted the next hearing to be about the National Vaccine Injury Compensation Program (NVICP):

“He [Mark Blaxill] said that he was merely representing the consensus of the community and that the community wanted the NVICP hearing first,” said Hooker.

Also contradictory to Blaxill’s claim that the action alert represented the “consensus of the community” was the fact that the alert emphasized NVICP and led the community to ask Congressional COGR to investigate it. When asked to make a correction to the alert, Blaxill replied:

“What’s done is done.”

After Blaxill, Larson and Kompothecras’ April 30th, 2013 meeting with congressmen including COGR Chairman Issa, Jennifer Larson gave $40,000 to the Darrell Issa Victory Fund in May. This in turn was followed by Issa’s sitting on a panel at the AutismOne 2013 conference held later that same month. Mark Blaxill introduced that panel.

After emails turned up in September of that year revealing Mark Blaxill’s role in sabotaging the omnibus autism proceeding – that both Drs. Hooker and Kompothecras are petitioners in – Kompothecras dismissed Blaxill’s actions as being from years prior. Yet the following month, Mark Blaxill said in a podcast interview that he was unapologetic about anything he has done. Small wonder that Dr. Hooker said that October, “I feel very betrayed by Dr. Gary” and has not heard much from him in the past year.

Then the congressional committee cancelled the December-scheduled NVICP hearing, noting the topic picked by Canary Party was overly divisive. Yet even after that, as well as revelations about Blaxill’s role in throwing the omnibus and his concealed pharmaceutical connections, Dr. Kompothecras still supports him and Canary Party.

According to a reliable source, the NVICP hearing is tentatively scheduled for July 15th, 2014; with Dr. Kompothecras’ help, the Canary Party is still undermining the congressional hearings that were meant to be about CDC research misconduct. In the mean time, Kompothocras has been having some legal troubles that range from him being investigated by the Florida Bar, to being sued by State Farm Insurance, and he  is suing Allstate Insurance and Bloomberg News.

Jake Crosby is editor of Autism Investigated. He is a 2011 graduate of Brandeis University with a Bachelor of Arts in both History and Health: Science, Society and Policy and a 2013 graduate of The George Washington University School of Public Health and Health Services with a Master of Public Health in Epidemiology. He currently attends the University of Texas School of Public Health where he is studying for a Ph.D. in Epidemiology.

American Citizens for Health Choice: Canary Party’s Fundraising Arm?

healthchoicecan

By Jake Crosby

There is supposedly a new group on the horizon that calls itself the American Citizens for Health Choice (ACHC). However, it appears to be a new incarnation of a political organization founded in 2011 that effectively caused the collapse of the congressional autism hearings: Canary Party.

All four board members listed on the ACHC website are either former or current heads of Canary Party, although only two mention their affiliations. Jennifer Larson lists her position as president and co-founder of Canary Party and Patti Carroll says she is executive director of Canary Party. Despite also being co-founder as well as chairman of Canary Party, however, Mark Blaxill lists no affiliation with Canary Party in his bio on the ACHC website, simply saying he is editor-at-large for the (Canary Party-sponsored) blog Age of Autism as well as a director of SafeMinds, although he publicly stepped down from the latter organization’s board of directors last year. Meanwhile, the fourth board member of ACHC, Ginger Taylor, lists no past affiliation with Canary Party despite having been its previous executive director and then its vice president before announcing her departure from the latter position and autism advocacy in general on New Year’s Day.

ACHC may try to make itself look like a unique organization but appears to be nothing more than Canary Party’s fundraising arm. An anonymous source informed me that several Canary Party parents got together to start this new fundraising organization founded on the same premises as the Canary Party’s –  fighting chronic disease and promoting individual choice. The mission statements on the homepage of each group’s website are also similar.

Here is the  Canary Party homepage description:

“The Canary Party is a movement created to stand up for the victims of medical injury, environmental toxins and industrial foods by restoring balance to our free and civil society and empowering consumers to make health and nutrition decisions that promote wellness.”

And here is the ACHC homepage description:

“Our group was formed in response to a study published in Academic Pediatrics that represented 43% of children (32 million) in the US suffers from a chronic health condition. It is our belief that these rates will continue to increase if parents are not aware of the unhealthy choices in their lifestyle such as industrial processed foods, side effects of vaccine choices, and other environmental and lifestyle factors.”

Although the premise as well as the leaders of the two organizations are the same, it is obvious from their websites that they are trying to look like independent organizations when they are anything but. Since Canary Party is not a non-profit and ACHC is, it would appear that the purpose of the latter organization is to act as a fundraising arm of the former organization. With only $687.12 in the bank by the end of 2013, Canary Party is in need of some new cash. Apparently, ACHC’s purpose is to fulfill that need. ACHC first started filing 990 forms in 2012, but it has yet to publicly announce its existence.

Addendum: As of the date of this post, the link to americancitizensforhealthchoice.org now re-directs to a website with the URL that simply reads healthchoice.org along with the following notification: “This site is down for maintenance. Please check back again soon.” However, the americancitizensforhealthchoice.org homepage can still be found archived.

Jake Crosby is editor of Autism Investigated. He is a 2011 graduate of Brandeis University with a Bachelor of Arts in both History and Health: Science, Society and Policy and a 2013 graduate of The George Washington University School of Public Health and Health Services with a Master of Public Health in Epidemiology. He currently attends the University of Texas School of Public Health where he is studying for a Ph.D. in Epidemiology.

Canary Party’s False Promises Led To Congressional Hearing Collapse

Hooker-Larson comment

(Click to enlarge)

By Jake Crosby

Above is a screenshot dated March 23rd of a Facebook post from Dr. Brian Hooker asking for people to call congressional staff and ask that the Congressional Committee on Oversight & Government Reform (COGR) specifically investigate data fraud committed by CDC to cover up the vaccine-autism link. Commenting beneath his Facebook post is none other than Jennifer Larson – President of the Canary Party:

“We are on it! Thanks Brian Hooker!”

But after weeks of planning a Canary Party Action Alert that was intended to support Brian Hooker’s investigation, suddenly Canary Party sent out an alert that did not represent what was promised to him:

“Chairman Issa stated there is nothing that is off-limits for what the OGR committee will continue to explore. Ask him to promptly schedule the next hearing to investigate government malfeasance in covering up the vaccine/autism connection including, as examples, the following areas:

• Evidence in the National Vaccine Injury Compensation Program showing clearly that vaccines can and do cause autism

• CDC’s cover-up of the thimerosal/autism connection

• CDC’s suppression of evidence of the autism epidemic”

This Action Alert reveals Canary Party’s strategy to shift the topic away from CDC’s cover-up of the thimerosal/autism connection. In the first bullet point, the Canary Party introduces NVICP as evidence that vaccines cause autism. Somehow, NVICP as evidence of vaccines’ link to autism later morphed into NVICP reform – the new topic for the next congressional hearing. But what happened to the topic promised to Dr. Hooker?

Not only was the CDC cover-up of thimerosal’s role in causing the autism epidemic buried in the middle of the Action Alert, but the wording was clearly favorable to the entirely different topic of NVICP. In fact, that was exactly what Canary Party’s Executive Director Patti Carroll asked for in a long letter she posted on the House Committee on Oversight & Government Reform’s Facebook page. And now, Canary Party claims NVICP was Issa’s idea all along, even though we can trace its origin to the above Action Alert.

Brian Hooker was not pleased with this turn of events and wrote on Facebook, “COGR is not ready for that investigation and I’ve been told by their staff many times that they do not yet have energy for the NVICP. We are so close to a CDC investigation. That is why I approached Jennifer about the Action Alert. The message is now confused. I’m very discouraged…”

Regarding the action alert specifically, Dr. Hooker commented:

“not effective… not what I talked to Jennifer about… very discouraged…”

He then expressed regret about the action alert entirely:

“If I would have know [sic] this, I would have withdrawn my request for an action alert.”

Sure enough, the December-scheduled NVICP hearing Canary Party requested (in violation of its promise to Dr. Brian Hooker) was cancelled. Without providing any direct quotes from those who cancelled the hearing , Canary Party immediately shifted blame on everything from interference by the vaccine industry to simply “poor timing”. The below quote from a legal source in direct contact with COGR Chairman Issa’s counsel, previously disclosed on Autism Investigated, tells an entirely different story:

“I was just informed by the Counsel for Chairman Issa that due to ‘great deal of reluctance about participating or being drawn into what they, in their private candid discussions with us, say they see as an overly divisive issue’ they are canceling the hearing.”

Certainly it was divisive of Canary Party to promise one thing and then suddenly deliver something else that aims to avoid the CDC’s suppression of evidence thimerosal causes autism. Similarly, it was divisive of Canary Party to misrepresent a vaccine-injured child’s case at its congressional briefing and then when her mother complained in the comments of the Canary Party-sponsored/edited Age of Autism blog, approve a barrage of anonymous attacks from commenters including one from an organizer of the briefing. Put them both together and the result is an overly divisive issue Congress is reluctant to touch.

At least three questions remain unanswered: Why did Canary Party introduce a new hearing topic when Brian Hooker was so close to exposing CDC malfeasance that legislators were grilling a top CDC official about vaccine safety? Why did Canary Party instead push for a topic that COGR has stated many times it is not ready to pursue? Lastly, why are members of the autism community still following the Canary Party?

Jake Crosby is editor of Autism Investigated. He is a 2011 graduate of Brandeis University with a Bachelor of Arts in both History and Health: Science, Society and Policy and a 2013 graduate of The George Washington University School of Public Health and Health Services with a Master of Public Health in Epidemiology. He currently attends the University of Texas School of Public Health where he is studying for a Ph.D. in Epidemiology.

 

Vaccine Industry Watchdog Responds to Forbes Defense of Mercury-Laced Vaccinations

BRIAN HOOKER, PHD, PE

Dr. Brian Hooker, PhD, says Forbes misrepresented congressional records and CDC studies

CHARLOTTE, N.C., Feb. 28, 2014 /PRNewswire-iReach/ — Last week, PhD biochemist Brian Hooker created a stir when he announced he had obtained sensitive documents from the CDC (Centers for Disease Control and Prevention) through Freedom of Information Act (FOIA) requests. According to Hooker, these documents implicated the vaccine preservative Thimerosal (50% mercury by weight) in causing autism and other neurodevelopmental disorders, revealing what he says CDC officials had long known, but never disclosed publicly: a 7.6-fold increase in autism during infancy after exposure. Emily Willingham, who frequently editorializes in support of the vaccine program, responded in Forbes by criticizing a news story that went viral on the subject of Dr. Hooker’s FOIA revelations.

(Photo: http://photos.prnewswire.com/prnh/20140228/MN73622)

Dr. Hooker methodically itemized “misrepresentations and outright errors” that he says appeared in Forbes.com. “Willingham either confused two CDC studies or intentionally deceived Forbes’ readers,” said Hooker. “There was one concealed study that found a very high association between Thimerosal and autism. That was the study that was kept from the public which I obtained. And there was a later study by the same researcher – CDC-paid epidemiologist Thomas Verstraeten – who had watered down the results of the earlier study to appear as if there were no association between Thimerosal and autism. That second study was made public even though it was fraudulent.  Willingham pointed to the conclusions of the later study and implied that they came from the earlier study.”

Although Willingham denies that the CDC researcher, Dr. Verstraeten, was under pressure to alter the results of the earlier study, Dr. Hooker points out that Verstraeten’s own email written at the time (an internal CDC document obtained through FOIA) reveals otherwise. Verstraeten’s subject line, “It just won’t go away,” refers to his difficulty in making the statistical association between Thimerosal and autism disappear.

Making an example of how he says Dr. Verstraeten hid that association in his reanalysis of the data on 400,000 infants, Dr. Hooker says Verstraeten did not include clinics within HMOs where there was a strong correlation between Thimerosal exposure and autism incidence. According to Hooker, “Willingham brazenly disregarded Verstraeten’s own chilling words: ‘All the harm is done in the first month [of life]…’ He wrote those words about the study I obtained.”  The abstracts of Verstraeten’s two studies and further comment on the controversy can be viewed here.

Dr. Hooker says Willingham misrepresented the congressional record when she selected quotes from a 2007 U.S. Senate report which falsely asserted that allegations of a cover-up are unsubstantiated. He considers the U.S. House of Representatives’ 2003 report titled Mercury in Medicine (the result of a 3-year investigation) a “scathing, 80-page indictment of the CDC regarding the Thimerosal coverup.”  The report concludes, “Our public health agencies’ failure to act is indicative of institutional malfeasance for self-protection and misplaced protectionism of the pharmaceutical industry.”

Willingham treated Verstraeten’s final, watered-down results as solid epidemiological evidence, when, according to Hooker, the final version of the Verstraeten study is fraught with statistical flaws, primarily “overmatching.” He provided an example:  the cases and controls received the same vaccination schedule and the same Thimerosal dosage; thus, no true comparison could be made.  Hooker says this invalidates all of the analyses (done separately for HMOs A, B and C).

Willingham quoted Verstraeten’s  2004 letter in the journal Pediatrics regarding his later, diluted study, omitting the fact that the CDC has used the study to exonerate Thimerosal despite Verstraeten calling the study “neutral.”  In addition, the 2004 Institute of Medicine (IOM) Immunization Safety Review (ISR) committee report used this as the only U.S. epidemiological study (among the 5 studies) as the basis to reject the Thimerosal-autism hypothesis, shutting the door on any further research.

“In light of Ms. Willingham’s enthusiastic defense of mercury in vaccines despite conclusive evidence of its harm to children, it is ironic that the tagline for her column is ‘I write about the science they are selling you.'” remarked Dr. Hooker. Thimerosal is still administered to pregnant women and infants via the flu shot.

Brian Hooker, PhD, PE is an associate professor of biology at Simpson University. His over 50 science and engineering papers have been published in internationally recognized, peer-reviewed journals. He has a son, aged 16, who developed normally but then regressed into autism after receiving Thimerosal-containing vaccines. Dr. Brian Hooker’s investigative research is sponsored by the Focus Autism Foundation, which is dedicated to informing the public about the cause(s) of the autism epidemic and the rise of chronic illnesses. To learn more, visit focusautisminc.org and ashotoftruth.org,  an educational website sponsored by Focus Autism.

AutismOne is co-sponsoring this message and is a non-profit 501(c)(3) organization that provides education and supports advocacy efforts for children and families touched by an autism diagnosis. To learn more, visit autismone.org.

Media Contact: Angela Medlin, A Shot of Truth, 1 866-498-2768, angela@ashotoftruth.org

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

 

SOURCE Brian Hooker, PhD, PE

RELATED LINKS
http://www.ashotoftruth.org

Forbes’ Emily Willingham Pretends CDC Study Results Don’t Exist

cdcabstracts

Editor’s Note: Click the above image to enlarge.

By Jake Crosby

Forbes’ writers seem to have trouble reading scientific abstracts. In December, its senior editor Matthew Herper cited a press release that contradicted the research he discussed to endorse the vaccine efficacy of Gardasil. That, however, pales in comparison to the type of misrepresentation contributor Emily Willingham made when she conflated an earlier, suppressed CDC analysis (left abstract in image) showing thimerosal is associated with autism with a later, watered-down analysis CDC distributed at a public meeting that showed no association (right abstract in image). All the more remarkable is that she is an autism parent herself and has a PhD in biology.

Following the press release by Focus Autism, AutismOne and A Shot of Truth about the earlier abstract uncovered by A Shot of Truth scientific advisor Dr. Brian Hooker, Willingham responded with a long and verbose article titled, “Is The CDC Hiding Data About Mercury, Vaccines, and Autism?” She then answered her own title with: “You know the rule. The answer is, ‘No.'”

One paragraph in, she was already getting basic facts of the abstract disastrously wrong: “In 1999, four authors affiliated with the CDC presented an abstract at a conference … a CDC conference for fellows of its Epidemic Intelligence Service (EIS).” The conference takes place annually in April, but the research project of thimerosal did not even begin until August of that year as pointed out by chemist and Coalition for Mercury-Free Drugs‘ secretary Dr. Paul King in a comment to me. That error of Willingham’s, however, could hardly have predicted what was to come.

Although she never linked to the abstract from her article, she did read it and quoted directly from it – noting that it compared a “highest exposure group” to an “unexposed group”. Though she acknowledged the study authors “reported an increased risk for nondegenerative neurological disorders,” she never acknowledged they included autism.

Then five paragraphs into her article she suddenly switched from talking about the long-suppressed abstract to talking about a later analysis  where no comparison of autism across highest-and-unexposed groups was included. The manuscript describing that analysis, dated June 1st, 2000, was presented at the closed Simpsonwood meeting of federal officials and pharmaceutical industry representatives the following week and then distributed by CDC at a public meeting of the Advisory Committee on Immunization Practices later that same month. That document Willingham cited was not concealed from the public for over a decade and did not show that thimerosal is associated with autism, unlike the abstract of the earlier analysis. Yet she spent the rest of her article discussing the later study as if it was the same CDC study cited in the press release circulated by Focus Autism, AutismOne and A Shot of Truth and later picked up by Health Impact News Daily whose headline she drew attention to.

She even quoted the lead investigator Dr. Thomas Verstraeten presenting the lack of association with autism in the later manuscript:

“This is the result for autism, in which we don’t see much of a trend except for a slight, but not significant, increase for the highest exposure. The overall test for trend is statistically not significant.”

Dr. Verstraeten was under considerable pressure to reanalyze the data to  make the association between thimerosal and neurological disorders disappear, as evidenced in an email he titled “It just won’t go away.”  He wrote “…some of the RRs [relative risks] increase over the categories and I haven’t yet found an alternative explanation… Please let me know if you can think of one.” He and his colleagues issued successive studies  watering down the original results and ultimately, as  Willingham conceded, he was hired by vaccine maker GlaxoSmithKline.

What Willingham never quoted, however, was the reported result for autism in the abstract of the earlier analysis that the press release was actually about:

“The relative risk (RR) of developing a neurologic development disorders was 1.8 (95% confidence intervals [CI] = 1.1-2.8) when comparing the highest exposure group at 1 month of age (cumulative dose  > 25 ug) to the unexposed group. Within this group we also found an elevated risk for the following disorders: autism (RR 7.6, 95% CI = 1.8-31.5), nonorganic sleep disorders (RR 5.0, 95% CI = 1.6-15.9), and speech disorders (RR 2.1, 95% CI=1.1-4.0).”

Apparently, Willingham is imitating CDC, as all the way back in 2004 one of the coauthors of both CDC analyses Dr. Frank DeStefano said in a presentation to the Institute of Medicine (IOM) that:

“In no analyses were significant increased risks found for ADD or autism”

In that same presentation, DeStefano also claimed the “Initial” analysis was a study dated February, 29th, 2000, where the association with autism originally reported in the suppressed abstract was apparently diluted away by combining the highest exposure category with a lower exposure category. The very existence of the positive research results from the long-suppressed study abstract was denied.

One decade later and Emily Willingham and Forbes Magazine are now following CDC’s lead, as are other vaccine industry talking heads.

Jake Crosby is editor of Autism Investigated. He is a 2011 graduate of Brandeis University with a Bachelor of Arts in both History and Health: Science, Society and Policy and a 2013 graduate of The George Washington University School of Public Health and Health Services with a Master of Public Health in Epidemiology. He currently attends the University of Texas School of Public Health where he is studying for a Ph.D. in Epidemiology.

Vaccine Industry Watchdog Obtains CDC Documents That Show Statistically Significant Risks of Autism Associated with Vaccine Preservative Thimerosal

gI_134518_3_logos

Biochemist Brian Hooker, scientific advisor to A Shot of Truth, reveals CDC knew of risks for over decade.

Charlotte, NC (PRWEB) February 19, 2014

For nearly ten years, Brian Hooker has been requesting documents that are kept under tight wraps by the Centers for Disease Control and Prevention (CDC). His more than 100 Freedom of Information Act (FOIA) requests have resulted in copious evidence that the vaccine preservative Thimerosal, which is still used in the flu shot that is administered to pregnant women and infants, can cause autism and other neurodevelopmental disorders.

Dr. Hooker, a PhD scientist, worked with two members of Congress to craft the letter to the CDC that recently resulted in his obtaining long-awaited data from the CDC, the significance of which is historic. According to Hooker, the data on over 400,000 infants born between 1991 and 1997, which was analyzed by CDC epidemiologist Thomas Verstraeten, MD, “proves unequivocally that in 2000, CDC officials were informed internally of the very high risk of autism, non-organic sleep disorder and speech disorder associated with Thimerosal exposure.”

When the results of the Verstraeten study were first reported outside the CDC in 2005, there was no evidence that anyone but Dr. Verstraeten within the CDC had known of the very high 7.6-fold elevated relative risk of autism from exposure to Thimerosal during infancy. But now, clear evidence exists. A newly-acquired abstract from 1999 titled, “Increased risk of developmental neurologic impairment after high exposure to Thimerosal containing vaccine in first month of life” required the approval of top CDC officials prior to its presentation at the Epidemic Intelligence Service (EIS) conference. Thimerosal, which is 50% mercury by weight, was used in most childhood vaccines and in the RhoGAM® shot for pregnant women prior to the early 2000s.

The CDC maintains there is “no relationship between Thimerosal-containing vaccines and autism rates in children,” even though the data from the CDC’s own Vaccine Safety Datalink (VSD) database shows a very high risk. There are a number of public records to back this up, including this Congressional Record from May 1, 2003. The CDC’s refusal to acknowledge thimerosal’s risks is exemplified by a leaked statement from Dr. Marie McCormick, chair of the CDC/NIH-sponsored Immunization Safety Review at IOM. Regarding vaccination, she said in 2001, “…we are not ever going to come down that it [autism] is a true side effect….” Also of note, the former director of the CDC, which purchases $4 billion worth of vaccines annually, is now president of Merck’s vaccine division.

Dr. Hooker’s fervent hope for the future: “We must ensure that this and other evidence of CDC malfeasance are presented to Congress and the public as quickly as possible. Time is of the essence. Children’s futures are at stake.” A divide within the autism community has led to some activists demanding that compensation to those with vaccine-injury claims be the top priority before Congress. Dr. Hooker maintains that prevention, “protecting our most precious resource – children’s minds,” must come first. “Our elected officials must be informed about government corruption that keeps doctors and patients in the dark about vaccine risks.”

Referring to an organization that has seen its share of controversy this past year, Dr. Hooker remarked, “It is unfortunate that SafeMinds issued a press release on my information, is accepting credit for my work and has not supported a worldwide ban on Thimerosal.”

Brian Hooker, PhD, PE, has 15 years experience in the field of bioengineering and is an associate professor at Simpson University where he specializes in biology and chemistry. His over 50 science and engineering papers have been published in internationally recognized, peer-reviewed journals. Dr. Hooker has a son, aged 16, who developed normally but then regressed into autism after receiving Thimerosal-containing vaccines.

Dr. Brian Hooker’s investigative research is sponsored by the Focus Autism Foundation.

The Focus Autism Foundation is dedicated to providing information to the public that exposes the cause or causes of the autism epidemic and the rise of chronic illnesses – focusing specifically on the role of vaccinations. To learn more, visit focusautisminc.org.

A Shot of Truth is a non-profit 501(c)(3) organization and educational website sponsored by Focus Autism.

AutismOne is a non-profit 501(c)(3) organization that provides education and supports advocacy efforts for children and families touched by an autism diagnosis. To learn more, visit autismone.org.

Originally posted on PRWeb.

Correction: As Coalition for Mercury-Free Drugs‘ Dr. Paul King pointed out, the year 1999 on the abstract specifies the year its lead investigator Thomas Verstraeten joined the EIS, but not the year of the abstract itself. The EIS conference the study authors planned to submit their abstract to took place during the year 2000.

SafeMinds Summed Up In One Comment

safemindscomment

By Jake Crosby

In a now-deleted comment I recently left under a press release posted by Lyn Redwood on the SafeMinds website that tried to take credit for uncovering suppressed CDC evidence for thimerosal causing autism, I wrote:

David Geier discovered the “Generation Zero” data, Lyn, not anyone at SafeMinds. Similarly, these “new disclosures” have already been publicly available on the CoMeD site for months. That you’re linking to it now does not make it “new.” In fact, none of the discovered CDC data showing statistically significant associations between thimerosal exposure and autism has ever been discovered by anyone at SafeMinds. Those who actually have discovered these research results have either been excluded from testifying before Congress by SafeMinds or been excluded from testifying in the omnibus autism proceeding on behalf of petitioners, also by SafeMinds.

SafeMinds never exposed the thimerosal cover-up, but rather is a part of it. In the weeks leading up to the 2012 congressional hearing, Lyn Redwood wrote in an email that it makes her “crazy” that Andrew Wakefield is crucified and Danish fugitive Poul Thorsen evades justice. Yet right after she said this, she gave up her speaking slot to a man who went to absurd lengths to falsely play down Thorsen’s role in the fraud that sought to exonerate thimerosal.  She backed out on the excuse she was picking up her son from his first college quarter, even though it ended two weeks before the hearing. She later claimed she was “very sad” Thorsen was not mentioned in SafeMinds’ congressional testimony before Congress, even though her actions led to Thorsen not being mentioned.

Now Lyn Redwood is announcing the release of this latest CDC information without crediting its discoverer, Dr. Brian Hooker.

Jake Crosby is editor of Autism Investigated. He is a 2011 graduate of Brandeis University with a Bachelor of Arts in both History and Health: Science, Society and Policy and a 2013 graduate of The George Washington University School of Public Health and Health Services with a Master of Public Health in Epidemiology. He currently attends the University of Texas School of Public Health where he is studying for a Ph.D. in Epidemiology.

Mark Blaxill’s Thimerosal Backtrack: An Act To Throw The Omnibus?

actIIthecurtainpostomnibus

By Jake Crosby

Following the disclosure of emails on Autism Investigated in which Mark Blaxill responded to the lead omnibus attorney in vaccine court with attacks on expert witnesses Dr. Mark and David Geier, Autism Investigated reader John Best made an astute observation about the attorney’s email. Within that email, the attorney wrote:

“…we realize that we have to  deal with the fact that the increase has continued beyond the removal of thimerosal, but we have to convince the Special Masters that something in the environment, perhaps several somethings, is triggering symptoms of ASD in many kids.”

To which John Best responded in a comment:

“The lawyers claimed they had to account for the increase [in autism] after thimerosal was all gone and that they had to blame something in the environment. So, the lawyers admitted right there that they were throwing the case intentionally. Too bad the statute of limitations for legal malpractice has passed. Those words are all that are needed to hang them.
Did they think the whole world was too stupid to know that shooting 25 mcg of thimerosal into pregnant women equated to 200 times the alleged “safe” dose of mercury?
Jake, you should have entitled this: Lawyers Admit Throwing Case.”

To which I responded:

“That was almost certainly Mark Blaxill’s doing:
http://www.autisminvestigated.com/mark-blaxill-danish-fraudulent/

He claimed to change his views in a 2007 email to Dr. Brian Hooker based on the premature conclusion that reported autism prevalence still going up in California was evidence against thimerosal’s role in the autism epidemic, yet also cited the very Danish numbers Blaxill once called “uninformative and potentially misleading” to defend thimerosal right after being informed of their fraudulent nature by Dr. Hooker. What this would suggest is that Blaxill’s representation of himself as a leading proponent of thimerosal’s significance in causing the autism epidemic only to backtrack from his position later was all just an act to sink the omnibus and strike a PR victory for pharma.”

The latest component of this act that I did not mention in the above comment, however, is Blaxill’s downplaying of harm from thimerosal and vaccines in general. Neither was mentioned in Mark Blaxill’s speech before Congress, nor are they in the mission statement of the Canary Party that he chairs and founded. Such minimization of thimerosal’s harm helps prevent some of the worst perpetrators of the thimerosal cover-up from facing justice for burying evidence of its role in causing the autism epidemic. And the lead actor pretends to have no ties to the pharmaceutical industry when he still does.

It is about time someone drew the curtain on his act.

Jake Crosby is editor of Autism Investigated and is diagnosed with an autism spectrum disorder. He is a 2011 graduate of Brandeis University with a Bachelor of Arts in both History and Health: Science, Society and Policy and a 2013 graduate of The George Washington University School of Public Health and Health Services with a Master of Public Health in Epidemiology. He currently attends the University of Texas School of Public Health where he is studying for a Ph.D. in Epidemiology.

Mark Blaxill Remains Connected To BCG – A Pharma-Tied Consulting Firm

boston_consulting_group

By Jake Crosby

Revelations about Mark Blaxill’s ties to his former employer the Boston Consulting Group (BCG) and its pharmaceutical clients – in contradiction to what he said in a recently recorded interview on Linderman Unleashed – have now come to the attention of Autism Investigated. These discoveries were made on the heels of even more troubling evidence coming to light: see the previous post about Mark Blaxill turning the lead omnibus attorneys against expert witnesses Dr. Mark and David Geier with baseless and profane attacks against them.

In spite of Mark Blaxill claiming on Linderman Unleashed that he was fired from the BCG – suggesting his autism advocacy played a role – he appears to have voluntarily left the firm for the purpose of starting his own company and for reasons wholly unrelated to autism. In fact, Blaxill still maintains ties to BCG despite no longer being employed with the firm as Senior Vice President and despite claiming he no longer has a conflict of interest “of any kind.” Blaxill also falsely claimed to have always consulted for non-pharmaceutical clients while a BCG executive, merely admitting the firm had pharmaceutical clients but he in fact concealed from Linderman’s audience that he had consulted for Merck during his BCG employment.

Here’s the story he gave on his podcast interview with Curt Linderman, dated October 24, 2013, regarding his BCG departure:

“And then in 2006 – early in 2006 not very long after Evidence of Harm came out – all of a sudden I found myself without a job, and I was no longer at the Boston Consulting Group…I did have issues that concerned me, and it actually didn’t stop me from speaking out, Curt, but it did worry me a little, and who knows? Maybe my worries were founded because I’m not working there anymore, and that was not my choice.”

However, the book Lords of Strategy: The Secret Intellectual History of the New Corporate World by Walter Kiechel tells a story about Mark Blaxill’s departure from Boston Consulting Group (BCG) that totally contradicts what Blaxill told Linderman. According to Kiechel:

“Blaxill wanted to push on to the issue of motivation, of why people worked on Linux for free, even into issues of creativity, but couldn’t find the time or support within the firm for exploring those dimensions. “The antibodies resisted that,” he says. In 2006, Blaxill left BCG to set up his own firm, 3LP Advisors, to concentrate on the intersection of strategy, intellectual property, and innovation.”  

In his interview on Linderman, Blaxill said 3LP Advisors was founded as a result of his firing from Boston Consulting Group, claiming the termination of his employment “was not my choice.” Yet not only was it his choice according to Kiechel, but in fact Blaxill left Boston Consulting Group so that he could found 3LP Advisors to practice his own business strategy the way he liked – nothing to do with autism.

Linderman then further questioned Blaxill specifically about his conflict of interest with Boston Consulting Group since 2006:

“To me it would seem as if you were still with this company and you still had this conflict of interest, and that is not the case since 2006?”

To which Blaxill replied by emphatically denying possession of any conflict of interest:

“Curt, I don’t have a conflict of interest of any kind now, and I have not had one for years. I haven’t had a conflict since I started the Age of Autism with JB Handley and Dan Olmsted and Kim Stagliano back in 2007. I haven’t had a conflict since I wrote the book The Age of Autism. I haven’t had a conflict since starting the Canary Party. The only time I had a conflict was when I was helping David Kirby and contributing to the Evidence of Harm book. And it’s even in the book, Curt; I have never hid the conflict. I’ve actually been public with people and open with people about the concerns I’ve had. So it’s not as though there is any great secrets I was keeping. And whatever concern I had, it is not operative any longer.”

However, Blaxill remains a board member of the Initiative for a Competitive Inner City (ICIC), which has received over $25,000 annually from Boston Consulting Group. Serving on the board with him is none other than Boston Consulting Group’s Chairman of the Board Carl Stern.

ICIC’s chairman and founder as well as Harvard Business School Prof. Michael Porter was thanked in no uncertain terms in the acknowledgements section of the book Blaxill coauthored in 2009 with his business partner Ralph Eckardt, “The Invisible Edge: Taking Your Strategy to the Next Level Using Intellectual Property:

“[The Boston Consulting Group Founder’s] ideas have been extended and enriched by the academic and consulting community in Boston, most notably by Harvard Business School Professor Michael Porter, on one hand, and our former colleagues at BCG on another.”

Blaxill and Eckardt then summed up their relationship with Prof. Porter as follows:

“Michael Porter has been a teacher, a collaborator, a client, and a friend.” 

It seems Blaxill and Eckardt are not the only ones with high praise for Prof. Porter. When Porter was awarded a prestigious University Professorship at Harvard, Merck’s then-chairman, president and CEO Raymond Gilmartin (who later resigned over the Vioxx scandal and became a Harvard Business School Professor himself) told the Harvard Gazette:

“Through his research, teaching, and writing, Mike Porter has made an indelible mark on businesses and markets everywhere. His leading-edge research has directly influenced the strategies and competitiveness of individual firms and the nation. More recently, he has helped to identify the key drivers of innovation, which has now become the basis of global competition. His insights are directly relevant to understanding the vital ingredients for success in a host of industries, including pharmaceuticals.”

Clearly Blaxill has much to gain by serving on ICIC’s board of directors with his former employer BCG’s Chairman of the Board while under Prof. Porter’s chairmanship. ICIC’s website boasts that the organization’s partners “gain as well as give.” It’s hard to fathom how Blaxill could honestly claim on Linderman to not possess a conflict of interest “of any kind.”

But Blaxill was not even honest in the Linderman interview about what he did during his past employment for BCG. He claimed:

“…I always worked with industrial companies, automotive, forest products, computers-type companies, but they also had pharmaceutical clients.”

But he did not solely work with those companies, because Blaxill consulted for Merck directly as a BCG employee himself. In 2010, he told me he had visited Merck’s headquarters in Whitehouse Station, New Jersey. Later at a 2011 gathering in Waltham, Massachusetts, where Blaxill announced his preliminary plans to found the Canary Party – I overheard him telling someone about his experience consulting for Merck, describing his former clients as “not that smart.”

Despite suggesting his departure from Boston Consulting Group was some sort of martyrdom for his autism advocacy and that he no longer has any ties to the firm, it appears that Mark Blaxill was not fired, but left on his own terms wholly unrelated to autism and even remains connected to his former employer who continues to serve pharmaceutical clients.

Jake Crosby is editor of Autism Investigated and is diagnosed with an autism spectrum disorder. He is a 2011 graduate of Brandeis University with a Bachelor of Arts in both History and Health: Science, Society and Policy and a 2013 graduate of The George Washington University School of Public Health and Health Services with a Master of Public Health in Epidemiology. He currently attends the University of Texas School of Public Health where he is studying for a Ph.D. in Epidemiology.

Mark Blaxill to Omnibus Attorneys: “how deeply f*cked up the world is when the Geiers are considered credible analysts and I am not.”

blaxillongeiers

By Jake Crosby

Click the above screenshot to enlarge the July 2007 email where then-Vice President of SafeMinds Mark Blaxill stated in email to omnibus autism proceeding attorneys Mike Williams and Tom Powers concerning petitioners’ expert witnesses Dr. Mark and David Geier:

“I hope you understand how deeply fucked up the world is when the Geiers are considered credible analysts and I am not.”

Blaxill succeeded in turning Williams against his own expert witnesses, as Williams responded: “I do understand”.

Autism Investigated has acquired this latest installment of troubling emails about the Geiers between Blaxill and Williams from a source that wishes to remain anonymous. Last October, Autism Investigated posted emails dated 2003-2004 in which Mark Blaxill disparaged expert witnesses Dr. Mark and David Geier to Mike Williams – saying the Geiers “can do our cause more harm than good,” calling their work “sloppy” and claiming he could “rip [their work] to shreds.” Those emails were also obtained from a confidential source. (See mercury toxicity expert Dr. Boyd Haley’s response to Blaxill’s claim.)

The long email from Mike Williams to which Blaxill was responding can be seen in the following screenshot and was addressed to Lyn Redwood, President of SafeMinds (now Vice President of SafeMinds). Copied on the email in addition to Blaxill were Tom Powers and SafeMinds’ then-Executive Director (now President) Sallie Bernard. Note also that Williams described pursuit of “experts other than Mark Geier” before lamenting, “if only Mark Blaxill had an MPH or equivalent.” (screenshot 1, click to enlarge)
fdup2

Further down in that email, Williams reveals how influenced he was by Blaxill, saying: “On the genetics issue, we need someone other than Mark Geier to say what Mark Blaxill and you all proved…” (screenshot 2, click to enlarge) Incredibly, Williams was persuaded that Dr. Geier, a geneticist, was incapable of speaking on the genetics issue even though his genetic research had won him presidential recognition. What’s more, his son David actually discovered results from CDC researcher Dr. Thomas Verstraeten’s epidemiological analyses of thimerosal exposure showing vastly increased risks for neurodevelopmental disorders including autism compared to those who weren’t exposed to thimerosal during the first month of life. That a seasoned attorney was so manipulated by Mark Blaxill should serve as a cautionary tale in light of current events.

fdup3
fdup4

Jake Crosby is editor of Autism Investigated and is diagnosed with an autism spectrum disorder. He is a 2011 graduate of Brandeis University with a Bachelor of Arts in both History and Health: Science, Society and Policy and a 2013 graduate of The George Washington University School of Public Health and Health Services with a Master of Public Health in Epidemiology. He currently attends the University of Texas School of Public Health where he is studying for a Ph.D. in Epidemiology.